October Pharma Co. shareholders gave a nod to distributing cash dividends of 5%, equivalent to EGP 0.50 per share at a total amount of EGP 3 million.

The company reported net profits of EGP 7.8 million for 2014, compared with EGP 18.4 million for the previous year.

The pharmaceutical company is capitalised at EGP 60 million, distributed across 6 million shares at EGP 10 par value each.